SJÖGREN
Clinical trials for SJÖGREN explained in plain language.
Never miss a new study
Get alerted when new SJÖGREN trials appear
Sign up with your email to follow new studies for SJÖGREN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Sjogren's drug CLN-978 enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug, CLN-978, in 36 adults with active, moderate to severe Sjogren's disease. The main goal is to check safety and side effects. Researchers will also measure how the drug affects immune cells and stays in the body. Participants receive the dru…
Matched conditions: SJÖGREN
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
Massive leukodystrophy biobank aims to unlock secrets of rare brain diseases
Knowledge-focused Recruiting nowThis study is creating a large collection of medical data and biological samples from people with leukodystrophies—rare disorders that damage the brain's white matter. Researchers will use this information to discover new genetic causes, develop better diagnostic tools, and track…
Matched conditions: SJÖGREN
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated May 26, 2026 06:24 UTC